Procter & Gamble Forecast, price target & analysts
Procter & Gamble Target price 2026 - Analyst rating & recommendation
Procter & Gamble Classifications & Recommendation
Procter & Gamble Price Target
| Target Price | $165.24 |
| Price | $167.10 |
| Deviation | 1.11% |
| Number of Estimates | 30 |
| 30 Analysts have issued a price target Procter & Gamble 2027 . The average Procter & Gamble target price is $165.24. This is 1.11% lower than the current stock price. The highest price target is $195.30 16.88% , the lowest is $144.43 13.57% . | |
| A rating was issued by 37 analysts: 19 Analysts recommend Procter & Gamble to buy, 17 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2027 of 1.11% . Most analysts recommend the Procter & Gamble stock at Purchase. |
Sales and Margin forecast 2027, 2028 to 2033
29 Analysts have issued a sales forecast Procter & Gamble 2027 . The average Procter & Gamble sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
25 Analysts have issued an Procter & Gamble EBITDA forecast 2027. The average Procter & Gamble EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
31 Procter & Gamble Analysts have issued a net profit forecast 2027. The average Procter & Gamble net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033
Procter & Gamble...
Current Procter & Gamble Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Oct 26 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 26 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 23 2026 |
| BNP Paribas |
Outperform
➜
Outperform
|
Unchanged | Oct 23 2026 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 23 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 23 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 23 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Oct 26 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 26 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 23 2026 |
|
Unchanged
BNP Paribas:
Outperform
➜
Outperform
|
Oct 23 2026 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 23 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 23 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 23 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
